Cotter Ann Marie 4
4 · Zomedica Corp. · Filed May 3, 2021
Insider Transaction Report
Form 4
Cotter Ann
Interim CFO
Transactions
- Exercise/Conversion
Common Stock, without par value
2021-05-03$0.11/sh+8,333$917→ 8,333 total - Exercise/Conversion
Stock option (right to buy)
2021-05-03−8,333→ 266,667 totalExercise: $0.11Exp: 2025-10-01→ Common Stock, without par value (8,333 underlying) - Exercise/Conversion
Common Stock, without par value
2021-05-03$0.19/sh+11,111$2,111→ 11,111 total - Sale
Common Stock, without par value
2021-05-03$1.06/sh−11,111$11,778→ 0 total - Sale
Common Stock, without par value
2021-05-03$1.06/sh−8,333$8,833→ 0 total - Exercise/Conversion
Stock option (right to buy)
2021-05-03−11,111→ 155,557 totalExercise: $0.19Exp: 2025-03-14→ Common Stock, without par value (11,111 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
- [F2]The option vest as to 25% on March 14, 2020, with 25% to vest annually thereafter.
- [F3]The option vests in 4 equal annual installments commencing October 1, 2020.